RN Mobile Menu


Rheumatology Network

Collaborative Care in the MACRA Era

Pointing to bariatric surgery as an example, Dr. Edward Lin suggests that collaborative care may be the new standard of healthcare in the MACRA era. (©AlilaMedicalMedia/Shutterstock.com)

Recent Content


To better understand Mendelian randomization and how it touches rheumatological conditions, researchers have analyzed existing results revealing a causal relationship.


Cushingoid appearance is a side effect of glucocorticoid use, but to date, there has been little knowledge about how glucocorticoids can change fat mass and redistribution.


Triple therapy in RA is infrequent, despite mounting evidence that this more cost-effective option might be as effective as treatment intensification with biologic disease-modifying antirheumatic drugs.


Rheumatoid arthritis patients who are in remission or have stable low disease activity should continue TNFi therapy to control flares, study finds.

This slideshow sums up the current literature on the practice of continuing or discontinuing therapies when rheumatoid arthritis is in remission or stable low disease activity.


Apremilast may represent a new oral treatment option for patients with psoriatic arthritis (PsA) and current skin involvement, according to a new study.


A new study finds that slightly more than one-third of the patients were adherent to their index biologic and almost half discontinued within 12 months of initiation of therapy.

By clicking Accept, you agree to become a member of the UBM Medica Community.